Benzinga | Oct 11, 2021 08:25AM EDT

Morgan Stanley Maintains Equal-Weight on NOV, Lowers Price Target to $17

Morgan Stanley maintains NOV (NYSE:NOV) with a Equal-Weight and lowers the price target from $18 to $17.